Dublin, May 13, 2021 (GLOBE NEWSWIRE) -- The "Global Cystic Fibrosis Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com's offering.

The research report, Global Cystic Fibrosis Epidemiology and Patient Flow Analysis - 2021, provides Cystic Fibrosis epidemiology, demographics, and patient flow. The data is presented by Pharma G7 countries including the US, France, Spain, Italy, UK, Japan.

The research provides population data to characterize Cystic Fibrosis patients, history of the disease at the population level (Cystic Fibrosis prevalence, Cystic Fibrosis incidence) and at the clinical level (from diagnosis to treated patients). It also helps to identify patient sub-groups (age, gender, sub-groups) to understand targeted population for research and development, commercialization.

Research scope:

The data from this research will help executives:

Key Topics Covered:

1. Research Methodology

2. Cystic Fibrosis Patients Definition

3. US Cystic Fibrosis Epidemiology and Patient Flow

4. Germany Cystic Fibrosis Epidemiology and Patient Flow

5. France Cystic Fibrosis Epidemiology and Patient Flow

6. Italy Cystic Fibrosis Epidemiology and Patient Flow

7. Spain Cystic Fibrosis Epidemiology and Patient Flow

8. UK Cystic Fibrosis Epidemiology and Patient Flow

9. Europe Cystic Fibrosis Epidemiology and Patient Flow

10. Japan Cystic Fibrosis Epidemiology and Patient Flow

11. Global Cystic Fibrosis Epidemiology and Patient Flow

For more information about this report visit https://www.researchandmarkets.com/r/tb6kxe